Genetics of dilated cardiomyopathy conduction disease

Progress in Pediatric Cardiology

Volumn 24, Issue 1, 2007, Pages 3-13

  Mestroni, Luisa ^a   Miyamoto, Shelley D ^b   Taylor, Matthew R G ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

Arrhythmia; Conduction disease; Dilated cardiomyopathy; Genetics; Muscular dystrophy; Sudden death

Indexed keywords

ABCC9 PROTEIN; DESMIN; DESMOPLAKIN; DYSTROBREVIN; DYSTROPHIN; EMERIN; ION CHANNEL; LAMIN A; LAMIN C; PHOSPHOLAMBAN; PRESENILIN 1; PRESENILIN 2; SARCOGLYCAN; SCN5A PROTEIN; SODIUM CHANNEL; UNCLASSIFIED DRUG;

ARRHYTHMOGENESIS; ATRIOVENTRICULAR BLOCK; CELL NUCLEUS MEMBRANE; CONGESTIVE CARDIOMYOPATHY; DANON DISEASE; DEFIBRILLATOR; GENE MUTATION; GENE STRUCTURE; GENETIC COUNSELING; GENETIC DISORDER; HEART ARRHYTHMIA; HEART DISEASE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT VENTRICLE DYSPLASIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; MOLECULAR GENETICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINUS NODE DYSFUNCTION; SUDDEN DEATH; WOLFF PARKINSON WHITE SYNDROME; X CHROMOSOME LINKED DISORDER;

EID: 35348914777     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2007.08.003     Document Type: Review

References (104)

1. Report, of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93 (1996) 841-842
2. Maron B.J., Towbin J.A., Thiene G., et al. Contemporary definitions and classification of the cardiomyopathies. Circulation 113 (2006) 1807-1816
3. Mestroni L., Maisch B., McKenna W.J., et al. Guidelines for the study of familial dilated cardiomyopathies. Eur Heart J 20 (1999) 93-102
4. Brodsky G.L., Muntoni F., Miocic S., Sinagra G., Sewry C., and Mestroni L. A lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 101 (2000) 473-476
5. Fatkin D., MacRae C., Sasaki T., et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341 (1999) 1715-1724
6. Taylor M.R.G., Fain P., Sinagra G., et al. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 41 (2003) 771-780
7. Buckley A.E., Dean J., and Mahy I.R. Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series. Heart 82 (1999) 105-108
8. Merchut M.P., Zdonczyk D., and Gujrati M. Cardiac transplantation in female Emery-Dreifuss muscular dystrophy. J Neurol 237 (1990) 316-319
9. Kass S., MacRae C., Graber H.L., et al. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat Genet 7 (1994) 546-551
10. Bonne G., Di Barletta M.R., Varnous S., et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21 (1999) 285-288
11. Sebillon P., Bouchier C., Bidot L.D., et al. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J Med Genet 40 (2003) 560-567
12. Arbustini E., Pilotto A., Repetto A., et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol 39 (2002) 981-990
13. Hershberger R.E., Hanson E.L., Jakobs P.M., et al. A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation. Am Heart J 144 (2002) 1081-1086
14. Meune C., Van Berlo J.H., Anselme F., Bonne G., Pinto Y.M., and Duboc D. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med 354 (2006) 209-210
15. Hutchison C.J., Alvarez-Reyes M., and Vaughan O.A. Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes?. J Cell Sci 114 (2001) 9-19
16. Mounkes L., Kozlov S., Burke B., and Stewart C.L. The laminopathies: nuclear structure meets disease. Curr Opin 13 (2003) 1-8
17. Hutchison C.J. Lamins: building blocks or regulators of gene expression?. Nat Rev Mol Cell Biol 3 (2002) 848-858
18. Lin F., and Worman H.J. Structural organization of the human gene (LMNB1) encoding nuclear lamin B1. Genomics 27 (1995) 230-236
19. Hoger T.H., Zatloukal K., Waizenegger I., and Krohne G. Characterization of a second highly conserved B-type lamin present in cells previously thought to contain only a single B-type lamin. Chromosoma 99 (1990) 379-390
20. Rober R.A., Weber K., and Osborn M. Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. Development 105 (1989) 365-378
21. Lehner C.F., Stick R., Eppenberger H.M., and Nigg E.A. Differential expression of nuclear lamin proteins during chicken development. J Cell Biol 105 (1987) 577-587
22. Stuurman N., Heins S., and Aebi U. Nuclear lamins: their structure, assembly and interactions. J Struct Biol 122 (1998) 42-66
23. Machiels B.M., Zorenc A.H., Endert J.M., et al. An alternative splicing product of the lamin A/C gene lacks exon 10. J Biol Chem 271 (1996) 9249-9253
24. Alsheimer M., von Glasenapp E., Schnolzer M., Heid H., and Benavente R. Meiotic lamin C2: the unique amino-terminal hexapeptide GNAEGR is essential for nuclear envelope association. Proc Natl Acad Sci U S A 97 (2000) 13120-13125
25. Berry D.A., Keogh A., and dos Remedios C.G. Nuclear membrane proteins in failing human dilated cardiomyopathy. Proteomics 1 (2001) 1507-1512
26. McKeon F.D., Kirschner M.W., and Caput D. Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins. Nature 319 (1986) 463-468
27. Muchir A., Bonne G., van der Kooi A.J., et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet 9 (2000) 1453-1459
28. Raffaele Di Barletta M., Ricci E., Galluzzi G., et al. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet 66 (2000) 1407-1412
29. De Sandre-Giovannoli A., Chaouch M., Kozlov S., et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 70 (2002) 726-736
30. Speckman R.A., Garg A., Du F., et al. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet 66 (2000) 1192-1198
31. Shackleton S., Lloyd D.J., Jackson S.N., et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 24 (2000) 103-104
32. Novelli G., Muchir A., Sangiuolo F., et al. Mandubuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum Genet 71 (2002) 426-431
33. Eriksson M., Brown W.T., Gordon L.B., et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423 (2003) 293-298
34. Bonne G., Mercuri E., Muchir A., et al. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol 48 (2000) 170-180
35. van der Kooi A.J., Bonne G., Eymard B., et al. Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. Neurology 59 (2002) 620-623
36. Sullivan T., Escalante-Alcalde D., Bhatt H., et al. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 147 (1999) 913-920
37. Cutler D.A., Sullivan T., Marcus-Samuels B., Stewart C.L., and Reitman M.L. Characterization of adiposity and metabolism in Lmna-deficient mice. Biochem Biophys Res Commun 291 (2002) 522-527
38. Lammerding J., Schulze P.C., Takahashi T., et al. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 113 (2004) 370-378
39. Mounkes L.C., Kozlov S., Hernandez L., Sullivan T., and Stewart C.L. A progeroid syndrome in mice is caused by defects in A-type lamins. Nature 423 (2003) 298-301
40. De Sandre-Giovannoli A., Chaouch M., Kozlov S., et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 70 (2002) 726-736
41. Buckley A.E., Dean J., and Mahy I.R. Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series. Heart 82 (1999) 105-108
42. Sakata K., Shimizu M., Ino H., et al. High incidence of sudden cardiac death with conduction disturbances and atrial cardiomyopathy caused by a nonsense mutation in the STA gene. Circulation 111 (2005) 3352-3358
43. Paulin D., Huet A., Khanamyrian L., and Xue Z. Desminopathies in muscle disease. J Pathol 204 (2004) 418-427
44. Paulin D., and Li Z. Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle. Exp Cell Res 301 (2004) 1-7
45. Bar H., Strelkov S.V., Sjoberg G., Aebi U., and Herrmann H. The biology of desmin filaments: how do mutations affect their structure, assembly, and organisation?. J Struct Biol 148 (2004) 137-152
46. Goldfarb L.G., Vicart P., Goebel H.H., and Dalakas M.C. Desmin myopathy. Brain 127 (2004) 723-734
47. Dalakas M.C., Park K.Y., Semino-Mora C., Lee H.S., Sivakumar K., and Goldfarb L.G. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med 342 (2000) 770-780
48. Dalakas M.C., Dagvadorj A., Goudeau B., et al. Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations. Neuromuscul Disord 13 (2003) 252-258
49. Arbustini E., Pasotti M., Pilotto A., et al. Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects. Eur J Heart Fail 8 (2006) 477-483
50. Olive M., Goldfarb L., Moreno D., et al. Desmin-related myopathy: clinical, electrophysiological, radiological, neuropathological and genetic studies. J Neurol Sci 219 (2004) 125-137
51. Li D., Tapscoft T., Gonzalez O., et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100 (1999) 461-464
52. Miyamoto Y., Akita H., Shiga N., et al. Frequency and clinical characteristics of dilated cardiomyopathy caused by desmin gene mutation in a Japanese population. Eur Heart J 22 (2001) 2284-2289
53. Taylor M.R.G., Slavov D., Ku L., et al. Prevalence of desmin mutations in dilated cardiomyopathy. Circulation 115 (2006) 1244-1251
54. Sjoberg G., Saavedra-Matiz C.A., Rosen D.R., et al. A missense mutation in the desmin rod domain is associated with autosomal dominant distal myopathy, and exerts a dominant negative effect on filament formation. Hum Mol Genet 8 (1999) 2191-2198
55. Dagvadorj A., Goudeau B., Hilton-Jones D., et al. Respiratory insufficiency in desminopathy patients caused by introduction of proline residues in desmin c-terminal alpha-helical segment. Muscle Nerve 27 (2003) 669-675
56. Kaminska A., Strelkov S.V., Goudeau B., et al. Small deletions disturb desmin architecture leading to breakdown of muscle cells and development of skeletal or cardioskeletal myopathy. Hum Genet 114 (2004) 306-313
57. Goldfarb L.G., Park K.-Y., Cervenacova L., et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 19 (1998) 402-403
58. Sugawara M., Kato K., Komatsu M., et al. A novel de novo mutation in the desmin gene causes desmin myopathy with toxic aggregates. Neurology 55 (2000) 986-990
59. Park K.Y., Dalakas M.C., Goebel H.H., et al. Desmin splice variants causing cardiac and skeletal myopathy. J Med Genet 37 (2000) 851-857
60. Lapidos K.A., Kakkar R., and McNally E.M. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res 94 (2004) 1023-1031
61. Finsterer J., and Stollberger C. The heart in human dystrophinopathies. Cardiology 99 (2003) 1-19
62. Bies R.D., Phelps S.F., Cortez M.D., Roberts R., Caskey C.T., and Chamberlain J.S. Human and Murine Dystrophin mRNA transcr. Nucleic Acids Res 20 (1992) 1725-1731
63. Tsubata S., Bowles K.R., Vatta M., et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 106 (2000) 655-662
64. Nigro V., de Sa Moreira E., Piluso G., et al. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in d-sarcoglycan gene. Nat Genet 14 (1996) 195-198
65. Sakamoto A. Electrical and ionic abnormalities in the heart of cardiomyopathic hamsters: in quest of a new paradigm for cardiac failure and lethal arrhythmia. Mol Cell Biochem 259 (2004) 183-187
66. Coral-Vazquez R., Cohn R.D., Moore S.A., et al. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell 98 (1999) 465-474
67. Araishi K., Sasaoka T., Imamura M., et al. Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice. Hum Mol Genet 8 (1999) 1589-1598
68. Roberts R.G. Dystrophins and dystrobrevins. Genome Biol 2 (2001) (REVIEWS3006)
69. Metzinger L., Blake D.J., Squier M.V., et al. Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy. Hum Mol Genet 6 (1997) 1185-1191
70. Ichida F., Tsubata S., Bowles K.R., et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 103 (2001) 1256-1263
71. Rampazzo A., Nava A., Malacrida S., et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 71 (2002) 1200-1206
72. McKoy G., Protonotarios N., Crosby A., et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratodera and woolly hair (Naxos disease). Lancet 355 (2000) 2119-2124
73. Tiso N., Stephan D.A., Nava A., et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10 (2001) 189-194
74. Gerull B., Heuser A., Wichter T., et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 37 (2004) 1162-1164
75. Beffagna G., Occhia G., Nava A., et al. Regulatory mutations in transforming growth factor-B3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res 65 (2005) 366-373
76. Norgett E.E., Hatsell S.J., Carvajal-Huerta L., et al. Recessive mutations in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Genet 9 (2000) 2761-2766
77. Norman M., Simpson M., Mogensen J., et al. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation 112 (2005) 636-642
78. Yang Z., Bowles N.E., Scherer S.E., et al. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res 99 (2006) 646-655
79. Pilichou K., Nava A., Basso C., et al. Mutations in Desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation (2006) 1171-1179
80. Greenlee P.R., Anderson J.L., Lutz J.R., Lindsay A.E., and Hagan A.D. Familial automaticity-conduction disorder with associated cardiomyopathy. West J Med 144 (1986) 33-41
81. Olson T.M., and Keating M.T. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest 97 (1996) 528-532
82. McNair W.P., Ku L., Taylor M.R.G., et al. A SCN5A mutation associated with dilated cardiomyopathy, conduction disorder and arrhythmia. Circulation 110 (2004) 2163-2167
83. Olson T.M., Michels V.V., Ballew J.D., et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 293 (2005) 447-454
84. Schott J.J., Alshinawi C., Kyndt F., et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 23 (1999) 20-21
85. Tan H.L., Bink-Boelkens M.T., Bezzina C.R., et al. A sodium-channel mutation causes isolated cardiac conduction disease. Nature 409 (2001) 1043-1047
86. Wang D.W., Viswanathan P.C., Balser J.R., George Jr. A.L., and Benson D.W. Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation 105 (2002) 341-346
87. Benson D.W., Wang D.W., Dyment M., et al. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest 112 (2003) 1019-1028
88. Schwartz P.J., Priori S.G., Dumaine R., et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med 343 (2000) 262-267
89. Wang Q., Shen J., Splawski I., et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80 (1995) 805-811
90. Chen Q., Kirsch G.E., Zhang D., et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392 (1998) 293-296
91. Groenewegen W.A., Firouzi M., Bezzina C.R., et al. A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res 92 (2003) 14-22
92. Hoorntje T., Alders M., van Tintelen P., et al. Homozygous premature truncation of the HERG protein: the human HERG knockout. In. Circulation (1999) 1264-1267
93. Bienengraeber M., Olson T.M., Selivanov V.A., et al. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet 36 (2004) 382-387
94. Tiso N., Stephan D.A., Nava A., et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10 (2001) 189-194
95. Li D., Parks S.B., Kushner J.D., et al. Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am J Hum Genet 79 (2006) 1030-1039
96. Schönberger J., Wang L., Shin J.T., et al. Mutations in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss. Nat Genet 37 (2005) 418-422
97. Schonberger J., Levy H., Grunig E., et al. Dilated cardiomyopathy and sensorineural hearing loss: a heritable syndrome that maps to 6q23-24. Circulation 101 (2000) 1812-1818
98. Schmitt J.P., Kamisago M., Asahi M., et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299 (2003) 1410-1413
99. Haghighi K., Kolokathis F., Gramolini A.O., et al. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc Natl Acad Sci U S A 103 (2006) 1388-1393
100. DeWitt M.M., MacLeod H.M., Soliven B., and McNally EM. Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy. J Am Coll Cardiol 48 (2006) 1396-1398
101. Sugie K., Yamamoto A., Murayama K., et al. Clinicopathological features of genetically confirmed Danon disease. Neurology 58 (2002) 1773-1778
102. Cuervo A.M. Autophagy: many paths to the same end. Mol Cell Biochem 263 (2004) 55-72
103. Taylor M.R.G., Carniel E., and Mestroni L. Cardiomyopathy, familial dilated. Orphanet J Rare Dis 1 (2006) 27
104. Yi G., Keeling P.J., Hnatkova K., et al. Usefulness of signal-averaged electrocardiography in evaluation of idiopathic-dilated cardiomyopathy in families. Am J Cardiol 79 (1997) 1203-1207